PL3512505T3 - Farmaceutyczne kompozycje wildagliptyny - Google Patents

Farmaceutyczne kompozycje wildagliptyny

Info

Publication number
PL3512505T3
PL3512505T3 PL17768140.0T PL17768140T PL3512505T3 PL 3512505 T3 PL3512505 T3 PL 3512505T3 PL 17768140 T PL17768140 T PL 17768140T PL 3512505 T3 PL3512505 T3 PL 3512505T3
Authority
PL
Poland
Prior art keywords
vildagliptin
pharmaceutical compositions
pharmaceutical
compositions
vildagliptin pharmaceutical
Prior art date
Application number
PL17768140.0T
Other languages
English (en)
Inventor
Sergio Arroyo Hidalgo
Mireia Pladevall Roses
Eric MIGUEZ DIEZ
Original Assignee
Galenicum Health S.L.U.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=59887294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3512505(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Galenicum Health S.L.U. filed Critical Galenicum Health S.L.U.
Publication of PL3512505T3 publication Critical patent/PL3512505T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL17768140.0T 2016-09-16 2017-09-18 Farmaceutyczne kompozycje wildagliptyny PL3512505T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16189135 2016-09-16
ES201731122 2017-09-15
PCT/EP2017/073492 WO2018050892A1 (en) 2016-09-16 2017-09-18 Vildagliptin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PL3512505T3 true PL3512505T3 (pl) 2023-08-07

Family

ID=59887294

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17768140.0T PL3512505T3 (pl) 2016-09-16 2017-09-18 Farmaceutyczne kompozycje wildagliptyny

Country Status (4)

Country Link
EP (1) EP3512505B1 (pl)
ES (1) ES2946233T3 (pl)
PL (1) PL3512505T3 (pl)
WO (1) WO2018050892A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1009406B (el) * 2017-10-03 2018-11-26 Φαρματεν Αβεε Φαρμακευτικο σκευασμα που περιλαμβανει βιλνταγλιπτινη και μεθοδος για την παρασκευη αυτου
TR201913472A2 (tr) * 2019-09-06 2021-03-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Vi̇ldagli̇pti̇n ve metformi̇n i̇çeren bi̇r kombi̇nasyon

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5150173A1 (es) 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
DK3366283T3 (da) 2004-01-20 2021-11-22 Novartis Ag Direkte sammenpresningsformulering og fremgangsmåde
AR050615A1 (es) 2004-08-27 2006-11-08 Novartis Ag Composiciones farmaceuticas para la administracion oral
GT200600008A (es) 2005-01-18 2006-08-09 Formulacion de compresion directa y proceso
MY152185A (en) 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
US20110165239A1 (en) 2008-09-24 2011-07-07 Laman Alani Pharmaceutical compositions of atorvastatin
JP5008703B2 (ja) 2009-08-18 2012-08-22 株式会社ソニー・コンピュータエンタテインメント コンテンツ作成支援装置、画像処理装置、コンテンツ作成支援方法、画像処理方法、および画像表示コンテンツのデータ構造
TR201010683A1 (tr) 2010-12-21 2012-07-23 Sanovel İlaç San. Ve Ti̇c. A.Ş. Vildagliptin formülasyonları.
PL2938362T3 (pl) 2012-12-27 2017-07-31 Zentiva Saglik Ürünleri San. Ve Tic. A.S. Proces granulacji na sucho do wytwarzania tabletkowych kompozycji metforminy i ich kompozycje
SI3086781T1 (sl) 2013-12-23 2023-12-29 Krka D. D., Novo Mesto Farmacevtski sestavek zaviralca dpp-iv v kombinaciji z metforminom

Also Published As

Publication number Publication date
ES2946233T3 (es) 2023-07-14
EP3512505A1 (en) 2019-07-24
EP3512505B1 (en) 2023-03-15
WO2018050892A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
IL265260B (en) pharmaceutical preparations
IL265360B (en) Pharmaceutical composition
IL262654A (en) Pharmacy preparation
GB201419257D0 (en) Pharmaceutical compositions
GB201618482D0 (en) Pharmaceutical compositions
IL249553A0 (en) Pharmaceutical preparations
IL265349A (en) Pharmaceutical composition
GB201705303D0 (en) Pharmaceutical compositions
GB201521462D0 (en) Pharmaceutical composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
IL255510A (en) Pharmaceutical compositions
PL3454838T3 (pl) Kompozycja farmaceutyczna
IL250817A0 (en) pharmaceutical preparations
GB201615917D0 (en) Pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
IL263999A (en) Pharmaceutical compositions
PL3512505T3 (pl) Farmaceutyczne kompozycje wildagliptyny
GB201615910D0 (en) Pharmaceutical composition
IL265436B (en) Pharmacy preparation
ZA201705782B (en) Pharmaceutical compositions
GB201620519D0 (en) Pharmaceutical composition
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
GB201520762D0 (en) Novel pharmaceutical compositions